| Qu, Lefeng |
NCT03683459: Safety and Efficacy Study of FemFlow Drug-Eluting Peripheral Balloon Catheter |
|
|
| Recruiting | N/A | 208 | RoW | FemFlow Drug-Eluting Peripheral Balloon Catheter | Lifetech Scientific (Shenzhen) Co., Ltd. | Femoral Artery Stenosis, Femoral Artery Occlusion, Popliteal Arterial Stenosis, Popliteal Artery Occlusion | 12/22 | 12/22 | | |
NCT04765605: Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study) |
|
|
| Active, not recruiting | N/A | 120 | RoW | WeFlow-Tbranch Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Type B Aortic Dissection | 12/26 | 12/26 | | |
| Ren, Shancheng |
NCT06228404: Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC |
|
|
| Recruiting | 1 | 18 | RoW | Enhanced autologous PSMA-CAR T | Shanghai Changzheng Hospital, Bioray Laboratories | Metastatic Castration-resistant Prostate Cancer, Castration-resistant Prostate Cancer | 05/25 | 12/25 | | |
NCT06586658: Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells |
|
|
| Recruiting | 1 | 9 | RoW | anti-CD70-CAR-T cells | Shanghai Changzheng Hospital, Shanghai First Song Biotechnology Co., LTD | Renal Cell Carcinoma | 07/27 | 07/27 | | |
SINO-TOP, NCT06238713: Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer |
|
|
| Recruiting | N/A | 480 | RoW | Single-port extraperitoneal robotic-assisted radical prostatectomy with Vattikuti Institute Prostatectomy（VIP） techniques, Multi-port transperitoneal robotic-assisted radical prostatectomy with bilateral intrafascial nerve-sparing techniques | Shanghai Changzheng Hospital, Shanghai Zhongshan Hospital, ShuGuang Hospital, The Third Affiliated Hospital of Naval Medical University, The First Affiliated Hospital of Guangzhou Medical University, Sir Run Run Shaw Hospital, Sichuan Provincial People's Hospital | Prostate Adenocarcinoma, Localized Prostate Carcinoma | 06/25 | 12/25 | | |
NCT06509919: Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer |
|
|
| Recruiting | N/A | 1100 | RoW | Blood draw | Shanghai Changzheng Hospital, Ningbo No. 1 Hospital, The First Affiliated Hospital of Guangzhou Medical University, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Soochow University, West China Hospital, Zhongda Hospital, Northern Jiangsu People's Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Prostate Cancer | 12/25 | 12/25 | | |
NCT06589154: The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis |
|
|
| Recruiting | N/A | 1000 | RoW | Prostatic or Pelvic MR, Prostatic Biopsy | Shanghai Changzheng Hospital, Ningbo No. 1 Hospital, The First Affiliated Hospital of Soochow University, The First Affiliated Hospital of Guangzhou Medical University, Jiangsu Provincial People's Hospital, Zhejiang University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, West China Hospital | Healthy People, Benign Prostatic Hyperplasia, Prostate Cancer | 09/25 | 09/25 | | |
NCT05707468: Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer |
|
|
| Not yet recruiting | N/A | 200 | RoW | ADT combined with abiraterone, neoadjuvant hormone and RT | Changhai Hospital | Oligometastatic Prostate Carcinoma | 03/25 | 03/28 | | |
